Anti-inflammatory actions of 15-deoxy-Δ12,14-prostaglandin J2 and troglitazone evidence for heat shock-dependent and-independent inhibition of cytokine-induced inducible nitric oxide synthase expression

Diabetes

Volumn 49, Issue 3, 2000, Pages 346-355

  Maggi Jr , Leonard B ^a   Sadeghi, Homayoun ^b   Weigand, Christina ^a   Scarim, Anna L ^a   Heitmeier, Monique R ^a   Corbett, John A ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NaturX   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; CYTOKINE; DELTA12 PROSTAGLANDIN J2; GAMMA INTERFERON; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; TROGLITAZONE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CELL DEATH; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME INHIBITION; HEAT SHOCK RESPONSE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0343415083     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.3.346     Document Type: Article

References (39)

1. Gepts W: Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14:619-333, 1965
2. Sibley RK, Sutherland DE, Goetz F, Michael AF: Recurrent diabetes mellitus in the pancreas iso- and allograft: a light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest 53:132-144, 1985
3. Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PGF, Gamble DR: In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 313:353-360, 1985
4. Reddy S, Liu W, Elliott RB: Distribution of pancreatic macrophages preceding and during insulitis in young NOD mice. Pancreas 8:602-608, 1993
5. Oschilewski U, Kiesel U, Kolb H: Administration of silica prevents diabetes in BB rats. Diabetes 34:197-199, 1985
6. Charlton B, Bacelj A, Mandel TE: Administration of silica particles or anti-Lyt2 antibody prevents beta-cell destruction in NOD mice given cyclophosphamide. Diabetes 37:930-935, 1988
7. Chung Y-H, Jun H-S, Kang Y, Hirasawa K, Lee B-R, Rooijen NV, Yoon J-W: Role of macrophages and macrophage-derived cytokines in the pathogenesis of Kilham rat virus-induced autoimmune diabetes in diabetes-resistant BioBreeding rats. J Immunol 159:466-471, 1997
8. Lacy PE: The intraislet macrophage and type I diabetes. Mount Sinai J Med 61:170-174, 1994
9. Lefkowith JB, Schreiner G, Cormier J, Handler ES, Driscoll HK, Greiner D, Mordes JP, Rossini AA: Prevention of diabetes in the BB rat by essential fatty acid-deficiency: relationship between physiological and biochemical changes. J Exp Med 171:729-743, 1990
10. Wright JR, Lefkowith JB, Schreiner G, Lacy PE: Essential fatty acid deficiency prevents multiple low-dose streptozotocin-induced diabetes in CD-1 mice. Proc Natl Acad Sci U S A 85:6137-6141, 1988
11. Schreiner GF, Fly W, Brunt E, Korber K, Lefkowith JB: Essential fatty acid depletion of renal allografts and prevention of rejection. Science 240:1032-1033, 1988
12. Lacy PE, Finke EH: Activation of intraislet lymphoid cells causes destruction of islet cells. Am J Phathol 138:1183-1190, 1991
13. Corbett JA, McDaniel ML: Intraislet release of IL-1 inhibits β-cell function by inducing β-cell expression of iNOS. J Exp Med 181:559-568, 1995
14. Arnush M, Scarim AL, Heitmeier MR, Kelly CB, Corbett JA: Potential role of resident islet macrophage activation in the initiation of autoimmune diabetes. J Immunol 160:2684-2691, 1998
15. Arnush M, Heitmeier MR, Scarim AL, Marino MH, Manning PT, Corbett JA: IL-1 produced and released endogenously within human islets inhihits β-cell function. J Clin Invest 102:516-526, 1998
16. Devchand PR, Keller H, Peters JM, Vazquez M, Gonzalez FJ, Wahli W: The PPA-Ralpha-leukotriene B4 pathway to inflammation control. Nature 348:39-43, 1996
17. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK: The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391:79-82, 1998
18. Jiang C, Ting AT, Seed B: PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 391:82-86, 1998
19. Koizumi TM, Negishi M, Ichikawa A: Induction of heme oxygenase by delta 12-prostaglandin J2 in porcine aortic endothelial cells. Prostaglandins 43:121-131, 1992
20. Amici C, Sistonen L, Santoro MG, Morimoto RI: Antiproliferative prostaglandins activate heat shock transcription factor. Proc Natl Acad Sci U S A 89:6227-6231, 1992
21. Colville-Nash PR, Qureshi SS, Willis D, Willoughby DA: Inhibition of inducible nitric oxide synthase by peroxisome proliferator-activated receptor agonists: correlation with induction of heme oxygenase 1. J Immunol 161:978-984, 1998
22. Scarim AL, Heitmeier MR, Corbett JA: Heat shock inhibits cytokine-induced nitric oxide synthase expression by rat and human islets. Endocrinol 139:5050-5057, 1998
23. Beckerman KP, Rogers HW, Corbett JA, Schreiher RD, McDaniel ML, Unanue ER: Release of nitric oxide during the T cell-independent pathway of macrophage activation: its role in resistance to listeria monocytogenes. J Immunol 150:888-895, 1993
24. McDaniel ML, Colca JR, Kotagal N, Lacy PE: A subcellular fractionation approach for studying insulin release mechanisms and calcium metabolism in islets of Langerhans. Methods Enzymol 98:182-200, 1983
25. Heitmeier MR, Scarim AL, Corbett JA: Interferon-γ increases the sensitivity of islets of Langerhans for inducible nitric-oxide synthase expression induced by interleukin-1. J Biol Chem 272:13697-13704, 1997
26. 15N] nitrate in biological fluids. Anal Biochem 126:131-138, 1982
27. Hill JR, Corbett JA, Baldwin AC, McDaniel ML: Nitric oxide production by rat insulinoma cell line RINm5F is specific for IL-1: a spectrophotometric IL-1 bioassay. Anal Biochem 236:14-19, 1996
28. Heitmeier MA, Scarim AL, Corbett JA: Double-stranded RNA-induced iNOS expression and IL-1 release by murine macrophages requires NF-κB activation. J Biol Chem 273:15301-15307, 1998
29. Mosmann TJ: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J Immunol Methods 65:55-63, 1983
30. Corbett JA, McDaniel ML: Selective inhibition of iNOS by aminoguanidine. Methods Enzymol 268:398-408, 1996
31. Needleman P, Turk J, Jakschik BA, Morrison AR, Lefkowith JB: Arachidonic acid metabolism. Ann Rev Biochem 55:69-102, 1986
32. Shimabukruo M, Zhou Y-T, Lee Y, Unger RH: Troglitazone lowers islet fat and restores beta cell function of Zucker diabetic fatty rats. J Biol Chem 273:3547-3550, 1998
33. Shimabukruo M, Koyama K, Lee Y, Unger RH: Leptin-or troglitazone-induced lipopenia protects islets from interleukin 1β cytotoxicity. J Clin Invest 100: 1750-1754, 1997
34. Kwon G, Corbett JA, Rodi CP, Sullivan PM, McDaniel ML: IL-1β induces the expression of nitric oxide synthase by rat islets of Langerhans and RINm5F cells: evidence for the involvement of NFKB in the signaling mechanism. Endocrinology 130:4790-4795, 1995
35. Bedoya FJ, Flodstrom M, Eizirik DL: Pyrrolidine dithiocarbamate prevents IL-1-induced nitric oxide synthase mRNA, but not superoxide dismutase mRNA in insulin producing cells. Biochem Biophys Res Commun 210:816-822, 1995
36. Welsh N: Interleukin-1β induced ceramide and diacylglycerol generation may lead to activation of the c-Jun NH2-terminal kinase and the transcription factor ATF2 in the insulin-producing cell line RINm5F. J Biol Chem 271:8307-8312, 1996
37. Bellmann K, Jaattela M, Wissing D, Burkart V, Kolb H: Heat shock protein hsp 70 overexpression confers resistance against nitric oxide. FEBS Lett 391:185-188, 1996
38. Margulis BA, Sandler S, Eizirik DL, Welsh N, Welsh M: Liposomal delivery of purified heat shock protein hsp 70 into rat pancreatic islets as protection against interleukin 1β-induced impaired β-cell function. Diabetes 40:1418-1422, 1991
39. Ye J, Laychock SG: A protective role for heme oxygenase expression in pancreatic islets exposed to interleukin-1β. Endocrinology 139:4155-4163, 1998